|Bid||53.25 x 800|
|Ask||55.00 x 800|
|Day's Range||53.44 - 54.52|
|52 Week Range||48.25 - 79.11|
|Beta (3Y Monthly)||1.68|
|PE Ratio (TTM)||58.58|
|Earnings Date||May 13, 2019 - May 17, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||66.78|
GuideStone Capital Management President David Spika joins Yahoo Finance's Adam Shapiro, Julie Hyman, Jared Blikre, and MIT Professor Sinan Aral.
DaVita HealthCare (DVA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
DENVER, April 25, 2019 /PRNewswire/ -- By 2022, DaVita Inc. (DVA) expects to use 100 percent renewable energy. The company has contracted with Longroad Energy on two virtual power purchase agreements (PPAs) facilitating the development of clean energy projects in Texas. Together, DaVita's share of these projects will generate as much renewable energy as the amount of electricity used by the company's North American operations.
DENVER, April 24, 2019 /PRNewswire/ -- DaVita Kidney Care, a division of DaVita Inc. (DVA), a leading provider of kidney care services in the United States, today introduced its multi-media kidney transplant education resource, Transplant Smart, which is available to its patients.
LOS ANGELES , April 23, 2019 /PRNewswire/ -- DaVita Kidney Care , a division of DaVita Inc. (NYSE: DVA), a leading provider of kidney care services in the United States , launches the DaVita Health Tour ...
Warren Buffett's big bet on kidney dialysis provider DaVita may finally be primed to start paying off, albeit after five frustrating years of negative returns.
SAN DIEGO, CA / ACCESSWIRE / April 15, 2019 / The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares of Davita Inc (NYSE: DVA). Investors who purchased shares ...
Looking at DaVita Inc.'s (NYSE:DVA) earnings update in December 2018, analysts seem fairly confident, with profits predicted to increase by 17% next year compared w...
DaVita (DVA) is gaining steadily from expansion in international markets, strong demand in dialysis services and prudent acquisitions. However, rising expenses remain a dampener.
Is DaVita Inc (NYSE:DVA) a good stock to buy right now? We at Insider Monkey like to examine what billionaires and hedge funds think of a company before doing days of research on it. Given their 2 and 20 payment structure, hedge funds have more incentives and resources than the average investor. The funds have […]
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into DaVita Inc. (DVA). On December 25, 2016, an article by the New York Times highlighted the relationship between the American Kidney Fund (“AKF”), a charity that helps patients pay for kidney dialysis, and its largest donors, including DaVita, suggesting that the AKF had denied charitable premium assistance (“CPA”) to patients of dialysis companies who did not donate to it.
NEW YORK , April 5, 2019 /PRNewswire/ -- AmpliPhi Biosciences Corporation (APHB) Lifshitz & Miller announces investigation into possible breach of fiduciary duties in connection with the sale of APHB ...
Shareholder rights law firm Robbins Arroyo LLP announces DaVita Inc. may face damages caused by a pending securities lawsuit action lawsuit. DaVita Inc. provides kidney dialysis services.
The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares of Davita Inc (DVA). Investors who purchased shares of Davita Inc (DVA) in February 2015 or earlier and continue to hold any of those NYSE: DVA shares should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 - 1554. On February 1, 2017, a lawsuit was filed against Davita Inc over alleged securities laws violations.
NEW YORK, March 28, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
Jeffry Gates’ Gates Capital Management is an event-driven alternative asset manager founded back in 1996, which managed around $2.69 billion on a discretionary basis at the end of 2016. Besides being its founder, Jeffrey Gates is the current President and Portfolio Manager of the fund, whose headquarters are in the Big Apple. Before launching his […]
LOS ANGELES and BALTIMORE, March 15, 2019 -- Kay Properties and Investments, LLC has completed another equity raise on a 100% occupied net lease property in Baltimore, MD. The.
DaVita HealthCare (DVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like to learn about Return On Equity (ROE) and why itRead More...
Davita Inc NYSE:DVAView full report here! Summary * Perception of the company's creditworthiness is positive * Bearish sentiment is low Bearish sentimentShort interest | PositiveShort interest is extremely low for DVA with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting DVA. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold DVA had net inflows of $3.83 billion over the last one-month. While these are not among the highest inflows of the last year, the rate of inflow is increasing. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swap | PositiveThe current level displays a positive indicator. DVA credit default swap spreads are near the lowest level of the last three years and indicate the market's continued positive perception of the company's credit worthiness.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.